Sarepta Therapeutics | SRPT - Umsatzerlöse





Der Umsatz Veränderung Datum
Acadia Pharmaceuticals USD 307.96M 39.9M 2026-06
Agios Pharmaceuticals USD 44.74M 25.94M 2026-06
Alnylam Pharmaceuticals USD 1.29B 120M 2026-06
Amgen USD 10.1B 1.48B 2026-06
BioCryst Pharmaceuticals USD 218.25M 188.3M 2026-06
Biogen USD 2.74B 490M 2026-06
BioMarin Pharmaceutical USD 990M 224M 2026-06
Capricor Therapeutics USD 11.13M 8.87M 2024-12
Daiichi Sankyo JPY 574.74B 12.26B 2026-06
Eli Lilly USD 22.97B 3.17B 2026-06
Gilead Sciences USD 7.8B 800M 2026-06
Incyte USD 1.67B 400M 2026-06
Insmed USD 425.49M 119.53M 2026-06
Ionis Pharmaceuticals USD 268M 22M 2026-06
Moderna USD 100M 289M 2026-06
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Neurocrine Biosciences USD 959M 148M 2026-06
Novavax USD 147.14M 76.69M 2025-12
Pfizer USD 15.03B 530M 2026-06
PTC Therapeutics USD 361M 88M 2026-06
Regeneron Pharmaceuticals USD 4.29B 690M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Sangamo BioSciences USD 356K 125K 2024-06
Sanofi EUR 11.95B 710M 2026-06
Sarepta Therapeutics USD 401.3M 329.5M 2026-06
Tectonic Therapeutic USD 0 0 2024-12
Ultragenyx Pharmaceutical USD 214M 78M 2026-06
Vertex Pharmaceuticals USD 3.33B 340M 2026-06